Management Team
We are Thrombolex
Thrombolex creates innovative and sophisticated endovascular catheters using unique pharmaco-mechanical technologies for the treatment of arterial and thromboembolic conditions (A+VTE).
The company is currently marketing multiple FDA-cleared devices that are all based on the BASHIR™ Endovascular Catheter platform technology.
Over
100 Years
Combined Experience
Multiple
Key Partners
In the medical field
“Our catheters’ unique design features help enable physicians to customize treatment to achieve optimal clinical outcomes for their patients.”
- Marvin Woodall
Executive Chairman
Board of Directors
Management
The Innovator
Dr. Riyaz Bashir created the BASHIR™ Endovascular Catheters in partnership with Thrombolex to dissolve blood clots quickly and effectively to improve the quality of life for patients suffering from arterial and venous thromboembolic (A+VTE) conditions.
“VTE has become a significant health concern in the US…causing up to 100,000 deaths each year. My inspiration was to develop a device that would provide better treatment outcomes by enhancing both endogenous and exogenous fibrinolysis.”
– Dr. Riyaz Bashir
Riyaz Bashir, MD, FACC, RVT, is a Professor of Medicine for the Lewis Katz School of Medicine at Temple University, (Philadelphia PA) and Director of Vascular and Endovascular Medicine at Temple University Hospital.
Clinical Excellence Committee
David Dexter, MD
Chief of Vascular Surgery, Sentara Healthcare
···
Medical Director – Vein Center of Virginia
Wissam Jaber, MD
Interventional Cardiologist
···
Professor of Medicine – Emory University
Director, Cardiac Catheterization Laboratory
Vlad Lakhter, DO
Interventional Cardiologist
···
Assistant Professor of Medicine – Lewis Katz School of Medicine
Temple University
Rob Lookstein,
MD, MHCDL
Interventional Radiologist
···
Executive Vice Chairman Diagnostic, Molecular and Interventional Radiology – Mount Sinai Health System
Professor of Radiology and Surgery – Ichan School of Medicine at Mount Sinai (ISMMS)
John Moriarity, MD
Interventional Radiologist
···
Vice Chair, Department of Radiological Sciences
Clinical Professor of Radiology and Medicine – David Geffen School of Medicine, UCLA
Pat Muck, MD
Vascular Surgeon
···
Chief of Vascular Surgery – Good Samaritan Hospital
Program Director, Vascular Fellowship and Integrated Residency
Greg Piazza,
MD, MS
Director, Vascular Medicine Section
···
Division of Cardiovascular Medicine – Brigham and Women’s Hospital
Associate Professor of Medicine – Harvard Medical School
Raj Pyne, MD
Interventional Radiologist
···
Medical Director, Vein Treatment Center
Program Director, Interventional Radiology Residencies – Rochester General Health
Parth Rali, MD
MD, FACC, MSCAI
Pulmonologist
···
Director, PERT Program
Associate Professor of Thoracic Medicine and Surgery – Lewis Katz School of Medicine
Temple University
Kenneth Rosenfield,
MD, FACC, MSCAI
Interventional Cardiologist
···
Section Head, Vascular Medicine and Intervention Chairman – Massachusetts General Hospital
···
Co-founder of the PERT Consortium
Eric Secemsky, MD
MSc, RPVI, FACC, FAHA, FSCAI, FSVM
Interventional Cardiologist
···
Division of Vascular Intervention – Beth Israel Deaconess Medical Center
Director of Cardiovascular Research and Assistant Professor of Medicine – Harvard Medical School
Scientific Advisory Board
Riyaz Bashir, MD, FACC, RVT
Interventional Cardiology
···
Professor of Medicine at Temple University School of Medicine
Anthony Comerota,
MD, FACS, FACC
Vascular Surgeon
···
Medical Director of the Heart & Vascular Institute Inova General Hospital
Kenneth Rosenfield,
MD, FACC, MSCAI
Interventional Cardiology
···
Section Head for Vascular Medicine and Intervention Chairman, STEMI & Acute MI QI Committee Massachusetts General Hospital
···
Co-founder of the PERT Consortium